Dr. Surendra H. Bodakhe
Professor
Work Experience
25 years of UG,PG, and Research.
Area of Specialization
Pharmacology
Projects & Patents
1. UGC SAP ‘Ethnopharmacological Studies of Traditional Medicinal Plants’ UGC 2011-2016 Worked as Deputy Coordinator Rs. 68.75 lakh (Completed) 2. A search for herbal anticataract drugs from Achanakmar forest area of Chhattisgarh state CCOST, Raipur 2015- 2017 Principal investigator Rs. 1.40 Lakh (Completed) 3. “Search for novel anticataract agents: Phytochemical and pharmacological investigation of unexplored medicinal plants of Chhattisgarh State” Ministry of Ayush, Extra Mural Research Scheme 2014-2019 Principal investigator Rs 25.70 Lakh (Completed)
Education
M.PHARM, (Pharmacology), Ph.D
Achievments/Awards/Honors
UGC Fellowship for M Pharm
Publications
Publications- 1. Singh A, Bodakhe SH. Resveratrol attenuates behavioural impairment associated with learning and memory in rats with diabetes induced by a high‐fat diet and streptozotocin. Br. J. Pharmacol. 2022 Jul 19. [Impact factor- 9.473] 2. Das A, Kashyap O, Singh A, Shree J, Namdeo KP and Bodakhe SH. Oxymatrine Protects TGFβ1-Induced Retinal Fibrosis in an Animal Model of Glaucoma. Front. Med. 2022. 8:750342. [Impact factor- 5.091] 3. Shree J, Singh A, Choudhary R, Pandey DP and Bodakhe SH. Topical Administration of ACE Inhibitor Interrupts the Progression of Cataract in Two Kidney One Clip Induced Hypertensive Cataract Model. Curr. Eye. Res. 2021 DOI: 10.1080/02713683.2021.2002911 [Impact factor: 2.424] 4. Shree J, Choudhary R, Bodakhe SH. Therapeutic effects of various renin angiotensin modulators on hyperglycemia-induced cataract formation in Sprague Dawley rats [published online ahead of print, 2020 Oct 4]. Eur J Ophthalmol. 2020;1120672120962401. doi:10.1177/1120672120962401 [Impact factor- 2.597] 5. Singh A, Bodakhe SH. Resveratrol delay the cataract formation against naphthalene-induced experimental cataract in the albino rats. J. Biochem. Mol. Toxicol. 2020 Jan;34(1):e22420. doi: 10.1002/jbt.22420 [Impact factor: 3.642] 6. Shree J., Choudhary R., Bodakhe S.H. Losartan delays the progression of streptozotocin‐induced diabetic cataracts in albino rats. J. Biochem. Mol. Toxicol. 2019. 33(8), e22342. doi: 10.1002/jbt.22342 [Impact factor: 3.642] 7. Soni P, Choudhary R, Bodakhe SH. Effects of a novel isoflavonoid from the stem bark of Alstonia scholaris against fructose-induced experimental cataract. J Integr Med. 2019;17(5):374-382. doi:10.1016/j.joim.2019.06.002 [Impact factor: 4.22] 8. Shrivastava P, Choudhary R, Nirmalkar U, Singh A, Shree J, Vishwakarma PK, Bodakhe SH. Magnesium taurate attenuates progression of hypertension and cardiotoxicity against cadmium chloride-induced hypertensive albino rats. J Tradit Complement Med. 2018;9(2):119-123. 2018. doi:10.1016/j.jtcme.2017.06.010 [Impact factor: 4.425] 9. Yadav A, Choudhary R, Bodakhe SH. Role of Nitric Oxide in the Development of Cataract Formation in CdCl2-induced Hypertensive Animals. Curr Eye Res. 2018;43(12):1454-1464. doi:10.1080/02713683.2018.1501490 [Impact factor: 2.424] 10. Gupta SK, Bodakhe SH. Development of pharmacological screening method for evaluation of effect of drug on elevated pulse pressure and arterial stiffness. J Pharmacol Toxicol Methods. 2018;91:59-65. doi:10.1016/j.vascn.2018.01.560 [Impact factor: 1.95] 11. Gupta N, Bhattacharya A, Bodakhe SH, Katare M. A case of melanosarcoma - in rat. Indian J. Anim. Res..2017;51:611-612. doi: 10.18805/ijar.v0iOF.7830 [Impact factor: 0.44] 12. Choudhary R, Bodakhe SH. Olmesartan, an angiotensin II receptor blocker inhibits the progression of cataract formation in cadmium chloride induced hypertensive albino rats. Life Sci. 2016;167:105-112. doi:10.1016/j.lfs.2016.10.012 [Impact factor: 6.780] 13. Choudhary R, Kapoor MS, Singh A, Bodakhe SH. Therapeutic targets of renin-angiotensin system in ocular disorders. J Curr Ophthalmol. 2016;29(1):7-16. Published 2016 Oct 20. doi:10.1016/j.joco.2016.09.009 [Impact factor: 1.818] 14. Khan SA, Choudhary R, Singh A, Bodakhe SH. Hypertension potentiates cataractogenesis in rat eye through modulation of oxidative stress and electrolyte homeostasis. J Curr Ophthalmol. 2016;28(3):123-130. Published 2016 Jun 11. doi:10.1016/j.joco.2016.05.001 [Impact factor: 1.818] 15. Detail of patents.: Sr No Patent Title Name of Applicant(s) Patent/Application No. Award Date Agency/ Country Status 1. Vision maze: An animal model for central vision detection Dr. Surendra H. Bodakhe, Dr. Jaya Shree, Dr. Amrita Singh, Ashmita Das, Shivani Behera, Onkar Kashyap 359856-001 12-10-2022 India Granted 2. Peripheral visual field testing maze in laboratory use. Shivani Behera, Ashmita Das, Dr. Surendra H. Bodakhe, Nirdesh Kumar, Km Neha Sharma, Geeta Singh, Nidhi Kumari, Dr. Jaya Shree, Dr. Amrita Singh 370401-001 12-10-2022 India Granted 3. Hedychium coronarium: A novel therapeutic remedy against glaucoma progression Dr. Surendra H. Bodakhe, Onkar Kashyap, Ashmita Das, Dr. Vinod D. Rangari, Dr. Kamta P. Namdeo, Dr. Jaya Shree, Dr. Amrita Singh, 202221049661 Filed on 31-08-2022 India Patent published, Awaiting NBA approval 4. A novel anti- fertility agent Agrawal S.S., Bodakhe S.H., Diwan Roma and Dhameja Pooja US 2003/0212105 A1 Nov. 13, 2003 USA Granted